Allworth Financial’s Kezar Life Sciences KZR Stock Holding History

Allworth Financial’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$371	–	5299
2026 Q1	$371	Hold	50	–	–	﹤0.01%	4801
2025 Q4	$315	Buy	+50	New	+$292	﹤0.01%	4630
2023 Q3	–	Sell	-3	Closed	-$81	–	3494
2023 Q2	$81	Sell	3 -5	-63%	-$130	﹤0.01%	3182
2023 Q1	$257	Buy	+8	New	+$463	﹤0.01%	2957

Allworth Financial's KZR Position: Q2 2026 in Review

Allworth Financial sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 50 shares — an estimated $371 sold.

Allworth Financial first reported a position in KZR in Q1 2023 and held it in 4 quarters. The position peaked at $371 in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Allworth Financial reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Allworth Financial sold 50 Kezar Life Sciences shares in Q2 2026, an estimated $371.
Allworth Financial first reported a position in Kezar Life Sciences in Q1 2023 and held it in 4 quarters.
Allworth Financial's Kezar Life Sciences position peaked at $371 in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.